Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|December 9, 2016
[Current status of surgical treatment of gastric gastrointestinal tumors: a national multi-center retrospective study]Xingyu Feng, Renjie Li, Peng Zhang, et al.Oncogene|August 3, 2026
Midkine-activated TRPA1+ cancer-associated fibroblasts promote immunotherapy resistance in gastric cancer through a WNT5A-mediated treg circuitHualong Zheng, Xiaoqian Ye, Linyong Zheng, et al.JAMA Network Open|December 20, 2021
Outcomes of Laparoscopic Total Gastrectomy Combined With Spleen-Preserving Hilar Lymphadenectomy for Locally Advanced Proximal Gastric Cancer: A Nonrandomized Clinical TrialChaohui Zheng, Yanchang Xu, Gang Zhao, et al.Gastroenterology|February 5, 2023
SOX9 Modulates the Transformation of Gastric Stem Cells Through Biased Symmetric Cell DivisionQiyue Chen, Kai Weng, Mi Lin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled TrialYanfeng Hu, Changming Huang, Yihong Sun, et al.JAMA|May 29, 2019
Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical TrialJiang Yu, Changming Huang, Yihong Sun, et al.JAMA Network Open|July 27, 2021
Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and AdenocarcinomaJianxian Lin, Yajun Zhao, Yanbing Zhou, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 11, 2020
Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinomaHualong Zheng, YaJun Zhao, Qingliang He, et al.Frontiers in Oncology|October 22, 2019
In-Hospital Mortality Risk Model of Gastric Cancer Surgery: Analysis of a Nationwide Institutional-Level Database With 94,277 Chinese PatientsZhouqiao Wu, Huimin Cheng, Fei Shan, et al.The Lancet. Oncology|July 12, 2021
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trialXiaotian Zhang, Han Liang, Ziyu Li, et al.Pageof 12